SOURCES SOUGHT
99 -- Drug for Prompt (Pre-Hospital) Treatment of Hemorrhagic Shock
- Notice Date
- 3/8/2021 3:57:26 AM
- Notice Type
- Sources Sought
- NAICS
- 541
— Professional, Scientific, and Technical Services
- Contracting Office
- W4PZ USA MED RSCH ACQUIS ACT FORT DETRICK MD 21702-5014 USA
- ZIP Code
- 21702-5014
- Solicitation Number
- W81XWH-20-RFI-JD4-01
- Response Due
- 4/8/2021 6:00:00 AM
- Archive Date
- 04/23/2021
- Point of Contact
- Jamie Diggs
- E-Mail Address
-
jamie.l.diggs.civ@mail.mil
(jamie.l.diggs.civ@mail.mil)
- Description
- Warfighter Protection and Acute Care�of the U.S. Army Medical Materiel Development Activity�has a requirement for development of a drug that would be useful for prompt treatment of hemorrhagic shock in humans. The desired benefits of the drug are that its administration would increase the probability of survival, reduce the need for other treatment products, and reduce the need for prompt medical evacuation. The following characteristics are desired: (1) The drug would most likely be administered promptly after injury, before blood or blood components are administered; however, a drug that would be administered as a pre-treatment, prior to injury, would also be of interest. (2) The drug would be administered in a low volume, to minimize the burden of transporting it and administering it. (3) The drug would be stable (retain its effectiveness) for at least one year over a broad temperature range. (4) The drug would be amenable to administration by several routes, such as oral, intravenous, intraosseous, and intramuscular.
- Web Link
-
SAM.gov Permalink
(https://beta.sam.gov/opp/38b42c3aa4d24e6299ae099f4ebab4c9/view)
- Record
- SN05936459-F 20210310/210308230123 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |